Analyst Ratings for Moderna (MRNA)
MRNA Rating Summary
MRNA Price Target Summary
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$43.24 (-17.7%)
* Over Last 12-Mos
Rating Score: 1.7 / 10
Percentile Rank: 12%
Avg. $ Target:
$43.24 (-17.7%)
* Over Last 12-Mos
Rating Score: 1.7 / 10
Percentile Rank: 12%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/28/2026 | Barclays | Eliana Merle | New Coverage | Equalweight (N/A) |
25.00 (N/A) |
47.99 (52.52) |
9.44% | Details |
| 1/6/2026 | UBS | N/A | New Coverage | Neutral (N/A) |
34.00 (N/A) |
32.17 (52.52) |
63.26% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
